Genius Sports (NYSE:GENI), which completed its combination with dMY Technology Group Inc. II in April 2021, announced this morning that it has started a solicitation of consents from holders of outstanding warrants to amend the exercise period so the warrants will expire on January 18, 2023, instead of on April 20, 2026.
If GENI is able to receive more than 50% approval from the warrant holders, then the holders will have the opportunity to exercise on a cashless basis and receive 0.26 common shares for each exercised warrant.
Additionally, Genius Sports issued warrant holders a notice indicating that the company has lowered the exercise price of the warrants from $11.50 to a price that is 74% of the closing price of the ordinary shares on the NYSE on the trading day prior to the date of delivery of an exercise notice. Yesterday’s close price was $4.49, which equates to $3.3226.
If the warrant amendment is approved, the warrants will stop trading on the NYSE on January 18, 2023 and all previously unexercised warrants will expire worthless on such date.
As of November 17, a total of 7,668,381 warrants were outstanding. The consent solicitation is expected to expire on its expiration date of December 16.
The company’s stock is currently down -2.48% in early morning trading following today’s announcement. GENI warrants (NASDAQ:GENIWS), however, are up about +50% to $1.20. Genius Sports hopes to simplify its capital structure and reduce the potential dilutive impact of the warrants through this solicitation, thereby providing the company with more financial flexibility.
dMY Technology Group, Inc. II originally announced its $1.5 billion combination with Genius Sports in October 2020 and completed the deal in April 2021. London-based Genius Sports supplies sports betting operators with official data and streaming media services and is partnered with about 500 sports organizations including the NBA, Premier League and NCAA.
Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 27, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...
CEO Marc Nemati and Colombier II’s Omeed Malik break down the deal and the strategy. Despite its moniker as the “the everything store” you can’t buy everything on Amazon, and firearms are one of those things. But, GrabAGun has spent years building a platform for regulated online firearms purchases, and soon, consumers will be able...
At the SPAC of Dawn Futures remain green after Fed Chairman Jerome Powell hinted at a July rate cut and tensions cooled for now in the Middle East. That has not warmed all corners of the SPAC market as teams continue to hit bumps in their shareholder votes this week. Four Leaf (NASDAQ:FORL) was the...
Lightwave Acquisition Corp. (NASDAQ:LWACU) announced the pricing of its $187.5 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LWACU”, Wednesday, June 25, 2025. The new SPAC plans to combine with a technology target or another industry that complements its management team’s background. Lightwave’s management team is led...